
|Articles|January 30, 2019
Payer and Specialty Pharmacy Forum: Clinical Updates and Outcomes Data for PCSK9 Inhibitors
https://www.pharmacytimes.org/on-demand/an-american-journal-of-managed-care-payer-and-specialty-pharmacy-forum-clinical-updates-and-outcomes-data-for-pcsk9-inhibitors
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
4
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
5









